5 Guru Picks In Volatile Biotech Industry |
| December 24, 2015 | December 2015 Bond Updates |
|
Biotech and pharmaceutical stocks made some of the biggest headlines this year, as 2015 saw massive waves of M&A activity, including the Pfizer (NYSE:PFE) and Allergan (NYSE:AGN) merger, the second-largest deal of all time valued at $160 billion. Other companies found themselves in the spotlight for less than desirable reasons, such as Valeant Pharmaceuticals (NYSE:VRX), whose stock has tanked in the past several months. |
| View more at: http://www.forbes.com/sites/gurufocus/2015/12/23/5-guru-picks-in-volatile-biotech-industry/ |
| Related News |
|